Harmony Biosciences Holdings (HRMY) EBIAT: 2019-2025
Historic EBIAT for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $50.9 million.
- Harmony Biosciences Holdings' EBIAT rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.7 million, marking a year-over-year increase of 51.42%. This contributed to the annual value of $145.5 million for FY2024, which is 12.91% up from last year.
- Per Harmony Biosciences Holdings' latest filing, its EBIAT stood at $50.9 million for Q3 2025, which was up 27.88% from $39.8 million recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' EBIAT registered a high of $87.9 million during Q3 2022, and its lowest value of -$9.6 million during Q3 2021.
- Over the past 3 years, Harmony Biosciences Holdings' median EBIAT value was $38.5 million (recorded in 2023), while the average stood at $37.3 million.
- Over the last 5 years, Harmony Biosciences Holdings' EBIAT had its largest YoY gain of 52,385.19% in 2021, and its largest YoY loss of 603.93% in 2021.
- Harmony Biosciences Holdings' EBIAT (Quarterly) stood at $22.7 million in 2021, then surged by 113.56% to $48.5 million in 2022, then slumped by 45.15% to $26.6 million in 2023, then skyrocketed by 85.95% to $49.5 million in 2024, then rose by 10.35% to $50.9 million in 2025.
- Its last three reported values are $50.9 million in Q3 2025, $39.8 million for Q2 2025, and $45.6 million during Q1 2025.